The Alliance for NanoHealth (ANH) and the Food & Drug Administration (FDA) are co-sponsoring a scientific workshop being held in Houston, Texas on March 10-12th, 2008.

The Alliance for NanoHealth (ANH) and the Food & Drug Administration (FDA) are co-sponsoring a scientific workshop being held in Houston, Texas on March 10-12th, 2008.
This workshop, called the FDA-ANH Nanotechnology Initiative Scientific Workshop, is an invitation-only event dedicated to obtaining feedback from stakeholders in an attempt to identify key scientific and translational challenges in nanoengineered medical product development.
In this regard, the organizers have assembled ∼50 key stakeholders from industry, Federal government, and academia.
A main deliverable of this workshop will be the development and publication of a short list of existing translational gaps and a the key elements that will be needed to bridge these gaps.
It is hoped that by implementing joint projects, having these key elements, we can work with stakeholders to overcome R&D hurdles, inform regulatory review of nanoengineered biomedical products, and ultimately, benefit patients. The results of the Workshop will be made available in the public domain.

Robert C. Hickey Auditorium (Hickey Auditorium)
M. D. Anderson Boulevard.
Houston